OS Therapies
Yahoo Finance • last month
Spotlight On AppLovin And 2 More Growth Stocks With Significant Insider Stakes
The United States market has shown robust performance, climbing 1.2% in the last week and rising 27% over the past year, with earnings projected to grow by 17% annually in the coming years. In such a thriving environment, growth companies... Full story
Yahoo Finance • last month
High Insider Stakes In Leading Growth Companies May 2026
The United States market has shown robust performance, climbing 1.8% in the last 7 days and up 28% over the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, growth companies with high insider owner... Full story
Yahoo Finance • 4 months ago
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology
VANCOUVER, British Columbia, March 19, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary — Big money is moving back into biotech. Institutional investors have been writing some of the largest checks in years, with major financi... Full story
Yahoo Finance • 8 months ago
OS Therapies GAAP EPS of -$0.21 misses by $0.08
* OS Therapies press release [https://seekingalpha.com/pr/20309223-os-therapies-reports-third-quarter-2025-financial-results-and-provides-business-update] (OSTX [https://seekingalpha.com/symbol/OSTX]): Q3 GAAP EPS of -$0.21 misses by $0.0... Full story
Yahoo Finance • 11 months ago
OS Therapies files $100M mixed securities shelf
* OS Therapies (NYSE:OSTX [https://seekingalpha.com/symbol/OSTX]) filed $100M mixed securities shelf. * Filing [https://seekingalpha.com/filing/10286300] MORE ON OS THERAPIES * Seeking Alpha’s Quant Rating on OS Therapies [https://... Full story
Yahoo Finance • last year
OS Therapies Announces Warrant Exercise Inducement & Exchange Offer
Current holders of five-year warrants with a current exercise price of $1.12 per share issued in connection with PIPE transaction initially closed on December 31, 2024 (Old Warrants) offered opportunity to exercise Old Warrants now to rece... Full story